GSK have sought European approval for a new Shingles Vaccination. The approval was sought after GSK completed a phase III clinical trial programme evaluating the efficacy, safety and immunogenicity of the new vaccine.
Other ILC sites:
ilcuk.org.uk | ilc-alliance.org
© 2015-2017 ILC-UK.
The text, photographs, audio and video on this site are released under a Creative Commons Licence.
Site design and development by CODESIGN